SCHEMBL10183904

SCHEMBL10183904

O=C1C(N(C(=O)Cc2cccs2)c2cccc(F)c2)c2ccccc2N1CC1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPK1 P28482 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ TRPA1 O75762 3/20 0.33
▸ AGTR2 P50052 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ IDH1 O75874 1/20 0.33
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185926 0.87 OPRM1 (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10183666 0.87 OPRM1 (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10185544 0.84 OPRM1 (0.40) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10183975 0.81 POLB (0.37) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10183767 0.81 OPRM1 (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10183314 0.78 CCKBR (0.37) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10184153 0.77 OPRM1 (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10185945 0.77 OPRM1 (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL18074198 0.76 SIGMAR1 (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB
SCHEMBL10184154 0.75 POLB (0.39) OPRM1OPRD1OPRK1SIGMAR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback